Proteomic identification of biomarkers of traumatic brain injury
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Traumatic brain injury (TBI) is a major national health problem without a US Food and Drug Administration-approved therapy. This review summarizes the importance of discovering relevant TBI protein biomarkers and presents logical rationale that neuroproteomic technologies are uniquely suited for the discovery of otherwise unnoticed TBI biomarkers. It highlights that one must make careful decisions when choosing which paradigm (human vs. animal models) and which biologic samples to use for such proteomic studies. It further outlines some of the desirable attributes of an ideal TBI biomarker and discusses how biomarkers discovered proteomically are complementary to those identified by traditional approaches. Lastly, the most important sequela of any proteomically identified TBI biomarker is validation in preclinical or clinical samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., & Aebersold, R. (1999) · Nature Biotechnology · doi:10.1038/13690 · Cited by 4,683
Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS
Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., & Gygi, S. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832254100 · Cited by 1,733 · cited 1×
“Potentially, differentially expressed proteins in TBI can also be further quantified using a MS-compatible method (see Denslow and coworkers [35]) such as isotope-coded affinity tags [36] or the use of absolute quantification probes [ 37 ].”
Method
Cited by
Mass Spectrometry Based Targeted Protein Quantification: Methods and Applications
Pan, S., Aebersold, R., Chen, R., Rush, J., Goodlett, D. R., McIntosh, M. W., Zhang, J., & Brentnall, T. A. (2009) · Journal of Proteome Research · doi:10.1021/pr800538n · Cited by 396
Hillered, L., Vespa, P. M., & Hovda, D. A. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.3 · Cited by 365
Papa, L., Lewis, L. M., Falk, J. L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G. M., Demery, J. A., Dixit, N. K., Ferguson, I., et al. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.08.021 · Cited by 332
Self-citationUbiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury*
Papa, L., Akinyi, L., Liu, M. C., Pineda, J. A., Tepas, J. J., Oli, M. W., Zheng, W., Robinson, G., Robicsek, S. A., Gabrielli, A., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b788ab · Cited by 308
Self-citationThalamic and Subthalamic Deep Brain Stimulation for Essential Tremor: Where Is the Optimal Target?
Sandvik, U., Koskinen, L.-O., Lundquist, A., & Blomstedt, P. (2012) · Neurosurgery · doi:10.1227/neu.0b013e318236a809 · Cited by 292
Metadata
- Authors
- Wang, K. K., Ottens, A. K., Liu, M. C., Lewis, S. B., Meegan, C., Oli, M. W., Tortella, F. C., & Hayes, R. L.
- Venue
- Expert Review of Proteomics
- Publisher
- Informa UK Limited
- Published
- 2005-08
- Volume
- 2
- Issue
- 4
- Pages
- 603-614
- ISSN
- 1478-9450 (ISSN-L)
- 1744-8387
- OpenAlex
- W2114655596
- Cited by
- 97
- References
- 2
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proteomic identification of biomarkers of traumatic brain injury. https://app.cochat.ai/papers/10.1586/14789450.2.4.603
- The paper
- Wang, K. K., Ottens, A. K., Liu, M. C., Lewis, S. B., Meegan, C., Oli, M. W., Tortella, F. C., & Hayes, R. L. (2005). Proteomic identification of biomarkers of traumatic brain injury. Expert Review of Proteomics. https://doi.org/10.1586/14789450.2.4.603
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.